Tuesday, March 19, 2019 4:00:20 PM
Last month Matthew talked about how they were in advanced proposals and discussions with big box retailer executives - specifically retailers like Target, CVS, Walgreens, and Rite-Aid (mentioned via email).
Matthew has mentioned to me previous to these tweets that each of these retailers were intrigued with the direction the industry was taking and what Innerscope had to offer.
CVS was still building out their hearing clinics at the time. None of the retailers said, "No." to Innerscope at that time. I believe that they were definitely intrigued because shortly after that time the move for CVS to close their hearing clinics was made official in preparation for the OTC Hearing Aid Act to pass next year.
IF Mark and Matthew are already closely working with CVS then a discussion of what will the now former-CVS audiologists and hearing aid specialists do? Where will they work? They didn't just lay off cashiers - it would have specifically been audiologists and hearing aid specialists. It makes sense for Innerscope to work with CVS on placing their employees (some of them anyways) at work at Innerscope if CVS is already planning on carrying the Nexus DTC (speculative on my part).
Leave work at CVS on a Friday - start work at Innerscope on a Monday.
CVS had 22 hearing clinics in California alone.
Additionally, with the potential DTC deal - CVS isn't (imo) going to try to sell their current name brand hearings aids DTC. If there is an equal or better, more cost effective hearing aid solution then as a Big Box retailer it's in their blood to carry that product.
The Nexus, according to Matthew, has all the same features as Eargo's hearing aids at half the cost.
Recent INND News
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 03/04/2024 10:30:06 PM
- InnerScope Hearing Technologies (OTC: INND) Retains SmallCapVoice.com to Amplify Investor Relations and Digital Marketing Initiatives • InvestorsHub NewsWire • 09/07/2023 12:00:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM